This review highlights that women have specific cardiovascular risk factors (e.g., hormonal therapy, pregnancy complications) and may be more susceptible to traditional risk factors.
Answers are grounded in this paper and cite their sources.
Supports incorporating sex-specific risk factors into women's CVD evaluation; leaves open need for prospective trials to guide practice.
Podle mnoha epidemiologickĂ˝ch studiĂ jsou Ĺženy vnĂmavÄjĹĄĂ k ĂşÄinkĹŻm kardiovaskulĂĄrnĂch rizikovĂ˝ch faktorĹŻ. KromÄ toho majĂ Ĺženy dalĹĄĂ pĹĂdatnĂŠ rizikovĂŠ faktory, specifickĂŠ pro jejich pohlavĂ: uĹžĂvĂĄnĂ hormonĂĄlnĂch orĂĄlnĂch kontraceptiv a nĂĄhradnĂ hormonĂĄlnĂ terapie, porody, toxickĂŠ komplikace tÄhotenstvĂ. Tato publikace popisuje dĹĂvÄjĹĄĂ i novÄjĹĄĂ vĂ˝sledky vĂ˝znamnĂ˝ch studiĂ, zamÄĹenĂ˝ch na genderovĂŠ rozdĂly v nemocnosti a Ăşmrtnosti na nemoci srdce a cĂŠv.
No takes yet. Share an insight, caveat, or question.
Greiffeneggová et al. (2017) conducted a review in Cardiovascular diseases. Cardiovascular risk factors (smoking, hormonal contraception, inflammation, pregnancy) vs. Men or women without risk factors was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: